FMC Corporation (FMC) Stock Analysis
Falling Knife setup
Basic Materials · Agricultural Inputs
Sell if holding. Engine safety override at $10.83: Quality below floor (1.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.0/10 and A.R:R 3.6:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 18%; Elevated put/call ratio: 22.78; Below-average business quality.
FMC Corporation is a global agricultural sciences company developing and marketing insecticides, herbicides, fungicides, and biological products to farmers across four geographic regions. Its two key franchises are Rynaxypyr active (~$0.8B revenue in 2025) and Cyazypyr active... Read more
Sell if holding. Engine safety override at $10.83: Quality below floor (1.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.0/10 and A.R:R 3.6:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 18%; Elevated put/call ratio: 22.78; Below-average business quality. Chart setup: Death cross, below all MAs, RSI 31, MACD bearish. Score 4.0/10, high confidence.
Passes 6/9 gates (favorable risk/reward ratio, clean insider activity, news events none recent, earnings proximity 49d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: aggressive.
Recent developments
updated 2026-06-11Recent Developments — FMC Corporation
Latest news
- NEWS Nasdaq 100 Falls 1% As 30-Year Yields Spike To 19-Year Highs: Stock Market Today — benzinga May 19, 2026 neutral
- NEWS FMC Agrees To Sell FMC India To Crystal Crop Protection For Consideration Of $252M — benzinga May 7, 2026 positive
- NEWS FMC Analysts Boost Their Forecasts Following Better-Than-Expected Q2 Results — benzinga May 1, 2026 positive
- NEWS Citigroup Maintains Neutral on FMC, Raises Price Target to $17 — benzinga May 1, 2026 positive
- NEWS RBC Capital Maintains Sector Perform on FMC, Raises Price Target to $17 — benzinga May 1, 2026 positive
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHSupplierChina and India suppliers10-K Item 1A: 'We source critical intermediates and finished products from a number of suppliers, largely outside of the U.S. and principally in China and India'
Material Events(8-K, last 90d)
- 2026-04-29Item 5.02LOWDirector Dirk A. Kempthorne (board member since 2009) passed away. FMC 2026 Incentive Stock Plan approved by shareholders at April 28, 2026 Annual Meeting, replacing the 2023 plan.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
6 floor-breakers
Revenue shrinking — -4.1% YoY. Growth thesis broken unless recovery story develops.static
Cyclical trough — margins compressed or negative. Profitability typically recovers with the cycle, but floor fires on current data.static
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Volatile — 6.1% daily ATR makes tight stops impractical. Position-size conservatively.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $10.83: Quality below floor (1.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.0/10 and A.R:R 3.6:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 18%; Elevated put/call ratio: 22.78; Below-average business quality. Chart setup: Death cross, below all MAs, RSI 31, MACD bearish. Prior stop was $10.46. Score 4.0/10, high confidence.
Take-profit target: $15.53 (+43.8% upside). Prior stop was $10.46. Stop-loss: $10.46.
Concentration risk — Supplier: China and India suppliers; Quality below floor (1.7 < 4.0).
FMC Corporation trades at a P/E of N/A (forward 5.2). TrendMatrix value score: 7.1/10. Verdict: Sell.
22 analysts cover FMC with a consensus score of 3.4/5. Average price target: $17.
What does FMC Corporation do?FMC Corporation is a global agricultural sciences company developing and marketing insecticides, herbicides,...
FMC Corporation is a global agricultural sciences company developing and marketing insecticides, herbicides, fungicides, and biological products to farmers across four geographic regions. Its two key franchises are Rynaxypyr active (~$0.8B revenue in 2025) and Cyazypyr active (~$0.4B); the India commercial business is in divestiture with a strategic review of the entire company announced February 2026.